1-11 of 11
uroporphyrinogen decarboxylase
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Identification of Polymorphic Gnpat As a Risk Factor for Porphyria Cutanea Tarda

John D Phillips, PhD, Colin P Farrell, MPH, Jessica Overbey, MS, Hetanshi Naik, BS, Gordon D. McLaren, MD, Christine E McLaren, PhD, Luming Zhou, PhD, Charles J. Parker, MD
Journal: Blood
Blood (2015) 126 (23): 3353.
https://doi.org/10.1182/blood.V126.23.3353.3353
Published: 2015
Journal Articles

A Retrospective Review of the Management of Patients with Porphyria Cutanea Tarda At a Tertiary Care Centre

Jovana Yudin, BSc, MD, Farzana R. Bacchus, MD, BSc, Mark A. Crowther, MD, FRCPC
Journal: Blood
Blood (2011) 118 (21): 5290.
https://doi.org/10.1182/blood.V118.21.5290.5290
Published: 2011
Journal Articles

Cellular Distribution of Porphyrins In Porphyria Cutanea Tarda

John D Phillips, PhD, Hector A Bergonia, James P. Kushner, MD
Journal: Blood
Blood (2010) 116 (21): 165.
https://doi.org/10.1182/blood.V116.21.165.165
Published: 2010
Journal Articles

A Pilot Study Investigating the Safety and Efficacy of Injectable Hemin (Panhematin®) in Patients with Low to Intermediate-1 Risk Myelodysplastic Syndrome.

Jamile Shammo
Journal: Blood
Blood (2009) 114 (22): 4859.
https://doi.org/10.1182/blood.V114.22.4859.4859
Published: 2009
Journal Articles

The Uroporphomethene Inhibitor Causitive for Porphyria Cutanea Tarda (PCT) Is Generated by Oxidation of Hydroxymethylbilane (HMB)

John D Phillips, PhD, Hector A Bergonia, Christopher A Reilly, Michael R Franklin, James P Kushner
Journal: Blood
Blood (2008) 112 (11): 3454.
https://doi.org/10.1182/blood.V112.11.3454.3454
Published: 2008
Journal Articles

HAMP and HVJ as Candidate Modifier Genes in Type1 Hereditary Hemochromatosis with High Iron Burden and in Porphyria Cutanea Tarda (PCT).

Richard S. Ajioka, PhD, John D. Phillips, Ph.D., Robert B. Weiss, Ph.D., Diane M. Dunn, M.S., James P. Kushner, M.D.
Journal: Blood
Blood (2006) 108 (11): 1544.
https://doi.org/10.1182/blood.V108.11.1544.1544
Published: 2006
Journal Articles

An Inhibitor of Uroporphyrinogen Decarboxylase (URO-D) Causes Porphyria Cutanea Tarda (PCT).

James P. Kushner, MD, Michael R. Franklin, PhD, Christopher P. Reilly, PhD, Hector A. Bergonia, MS, John D. Phillips, PhD
Journal: Blood
Blood (2006) 108 (11): 270.
https://doi.org/10.1182/blood.V108.11.270.270
Published: 2006
Journal Articles

Crystal Structure of Coproporphyrinogen Oxidase (CPO).

John D. Phillips, PhD, Frank G. Whitby, PhD, Christopher P. Hill, PhD, James P. Kushner, MD
Journal: Blood
Blood (2004) 104 (11): 52.
https://doi.org/10.1182/blood.V104.11.52.52
Published: 2004
Journal Articles

“Affenmensch” defect defined

Shigeru Sassa
Journal: Blood
Blood (2001) 98 (12): 3177.
https://doi.org/10.1182/blood.V98.12.3177
Published: 2001
Journal Articles

Functional consequences of naturally occurring mutations in human uroporphyrinogen decarboxylase

John D. Phillips, Tiffany L. Parker, Heidi L. Schubert, Frank G. Whitby, Christopher P. Hill, James P. Kushner
Journal: Blood
Blood (2001) 98 (12): 3179–3185.
https://doi.org/10.1182/blood.V98.12.3179
Published: 2001
Journal Articles

Correction of Uroporphyrinogen Decarboxylase Deficiency (Hepatoerythropoietic Porphyria) in Epstein-Barr Virus-Transformed B-Cell Lines by Retrovirus-Mediated Gene Transfer: Fluorescence-Based Selection of Transduced Cells

Antonio Fontanellas, Frédéric Mazurier, François Moreau-Gaudry, Francis Belloc, Cécile Ged, Hubert de Verneuil
Journal: Blood
Blood (1999) 94 (2): 465–474.
https://doi.org/10.1182/blood.V94.2.465
Published: 1999